Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

The claim: Moderna vaccine has poisonous SM-102 chemical in it. More than 60% of adults have now received at least one dose of a coronavirus vaccine, and as the CDC has issued new guidance on mask ...

FDA authorizes Pfizer-BioNTech, Moderna boosters for all adults Officials hope the signoff injects new urgency about the importance of the extra shots. Updated November 19, 2021 More than 3 years ago ...

FDA plans to “move rapidly” to add a warning to fact sheets for Pfizer and Moderna’s Covid-19 vaccines about the rare risk of developing inflammatory heart conditions, an agency official ...

This is the 19th column I’ve written about Balance Sheet Powerhouses. My picks from a year ago were up 45.1%, while the Standard & Poor’s 500 Total Return Index was down 5.5%.

Moderna’s stock remains far below its 52-week high of $170.47 and is down more than 65% over the past year. ... Its strong balance sheet and cash reserves offer some buffer, ...

Moderna, the biotech company behind one of the original mRNA COVID-19 vaccines, is undergoing an AI-powered workplace transformation. In partnership with OpenAI, Moderna has created thousands of ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its ...

Moderna and Merck have a good head start on the competition. The jointly developed mRNA-4157/V940 is a truly personalized vaccine tailored to the neoantigens found is the patient’s tumor.

UPDATE (9/6/23): This story has been updated with information from a Moderna clinical trial suggesting its updated vaccine is effective against EG.5. A new strain of COVID-19 called EG.5 has been ...

UPDATE (9/6/23): This story has been updated with information from a Moderna clinical trial suggesting its updated vaccine is effective against EG.5. A new strain of COVID-19 called EG.5 has been ...